Akorn, Inc. 2022-10-05 Health serious FDA
Health · FDA · Recall #FDA-D-1547-2022
Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating… Recall
Issued October 5, 2022 · Akorn, Inc.
In October 2022, Akorn, Inc. recalled the Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).
What you should do
- 1 Stop using Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Akorn, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Akorn, Inc.
- Category
- Health
- Recall date
- October 5, 2022
- Units affected
- Not reported
- Sold at
- USA Nationwide and Puerto Rico
- Recall number
- FDA-D-1547-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Akorn, Inc. has 63 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.